Stay updated on Olaparib in Metastatic Prostate Cancer (PROfound Study) Clinical Trial
Sign up to get notified when there's something new on the Olaparib in Metastatic Prostate Cancer (PROfound Study) Clinical Trial page.

Latest updates to the Olaparib in Metastatic Prostate Cancer (PROfound Study) Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe updated page shows a minor revision from v3.4.1 to v3.4.2. No study record data or history entries were altered.SummaryDifference0.1%

- Check20 days agoChange DetectedRevision: v3.4.1 replaces v3.4.0 in the page history, representing a minor UI/version label update. No study data or content were changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check27 days agoChange DetectedGlossary is now shown and color-coded highlights (green for additions, red for deletions) are used on the history page. The revision note was updated to v3.4.0 and the 'No FEAR Act' data wording has changed.SummaryDifference0.6%

- Check42 days agoChange DetectedThe page history shows a new revision entry v3.3.4 replacing v3.3.3 for the record NCT02987543; no substantive study data, eligibility, or results changes are shown. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedA new revision entry 'Revision: v3.3.3' has been added to the record history. The footer now excludes 'HHS Vulnerability Disclosure' and the previous 'Revision: v3.3.2' reference.SummaryDifference0.1%

- Check91 days agoChange DetectedThe record history page now includes a new site revision entry (v3.3.2) and removes the previous entry (v3.2.0).SummaryDifference0.1%

Stay in the know with updates to Olaparib in Metastatic Prostate Cancer (PROfound Study) Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Olaparib in Metastatic Prostate Cancer (PROfound Study) Clinical Trial page.